Financials
- Market Capitalization 625.57 M
- Employee 808
- Founded 2006
- CEO Timothy R Wright
- Website www.mimedx.com
- Headquarter Georgia, United States
- FIGI BBG000RJ6FL5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2764 | RGNX REGENXBIO Inc. - Common Stock | 12.29 USD | -3.61% | -19.93% | +81.00% | -8.49% | 635.36 M USD | ||
| 2769 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.50 USD | +2.52% | -6.74% | +9.24% | -21.31% | 630.68 M USD | ||
| 2779 | NGNE Neurogene Inc. - Common Stock | 39.19 USD | +2.27% | +8.02% | +33.57% | +33.21% | 619.28 M USD | ||
| 2781 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.82 USD | +4.60% | -7.94% | +30.75% | +4.60% | 617.91 M USD |
Frequently asked questions about MiMedx Group, Inc - Common Stock
What is the MiMedx Group, Inc - Common Stock stock price today?
The current price of MiMedx Group, Inc - Common Stock (MDXG) is 4.2. Over the past 24 hours, the stock has changed by +2.94%. Follow the MDXG chart for real-time price dynamics.
What is the stock ticker of MiMedx Group, Inc - Common Stock?
MiMedx Group, Inc - Common Stock trades under the ticker MDXG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MiMedx Group, Inc - Common Stock stock going up?
MDXG has changed by +1.69% over the last week, +15.07% over the last month, and -32.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MiMedx Group, Inc - Common Stock net income for the last quarter?
MiMedx Group, Inc - Common Stock reported net income of -10.86 M for the last quarter. The previous quarter showed 15.19 M, which means net income changed by -171.50%.
How many employees does MiMedx Group, Inc - Common Stock have?
As of the latest available data, MiMedx Group, Inc - Common Stock has 808 employees. Workforce size can provide additional context about the company's scale and operations.
What is MiMedx Group, Inc - Common Stock EBITDA?
MiMedx Group, Inc - Common Stock EBITDA is -16.68 M, and its EBITDA margin is -28.28%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MiMedx Group, Inc - Common Stock stock?
You can buy MiMedx Group, Inc - Common Stock (MDXG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MiMedx Group, Inc - Common Stock stock?
Investing in MiMedx Group, Inc - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MDXG chart and related analysis on metatrader.com as part of your research.